Market Intel 2018: Hemodialysis, MIGs And Liquid Biopsy Make Waves
Executive Summary
A look back at the five most-read Market Intelligence features of 2018 reveals a diverse mix of interests by our readers – hemodialysis, ophthalmic surgical solutions, liquid biopsy, digital solutions for diabetes management and a futuristic look at robotic pills to deliver drugs.
You may also be interested in...
Market Intel: Large Providers Focus On Hemodialysis Home Care; New Incentive By Presidential Executive Order
Momentum is rising for patients with chronic kidney disease to be treated with hemodialysis in the comfort of their own home as opposed to traveling several days a week to a freestanding clinic. Manufacturers, government and payers are paving the way for a higher home-therapy adoption rate. That said, many patients remain unsuitable for home care and the large volume of water needed to operate hemodialysis can be logistically daunting.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion
Two Chairs, which uses algorithms to match the right therapists with patients, secured $72m in investment to expand its business.